Lupin, Google, China Copyright: Intellectual Property

Lupin Ltd. won an appeals court ruling yesterday that lets it continue selling a generic version of the Shionogi Pharma Inc. diabetes drug Fortamet.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.